Implementation of the Women's Health Initiative study design.

[1]  H. Bergmeyer.  Methods of Enzymatic Analysis , 2019 .

[2]  B E Ainsworth,et al.  Compendium of physical activities: an update of activity codes and MET intensities. , 2000, Medicine and science in sports and exercise.

[3]  A. Kristal,et al.  Measurement characteristics of the Women's Health Initiative food frequency questionnaire. , 1999, Annals of epidemiology.

[4]  A. Kristal,et al.  Evaluation of a simplified vitamin supplement inventory developed for the Women's Health Initiative , 1999, Public Health Nutrition.

[5]  A. Kristal,et al.  Associations of race/ethnicity, education, and dietary intervention with the validity and reliability of a food frequency questionnaire: the Women's Health Trial Feasibility Study in Minority Populations. , 1997, American journal of epidemiology.

[6]  Victor Kipnis,et al.  Approaches to monitoring the results of long-term disease prevention trials: Examples from the Women's Health Initiative , 1996 .

[7]  C. Lewis,et al.  The Women's Health Trial Feasibility Study in Minority Populations: design and baseline descriptions. , 1996, Annals of epidemiology.

[8]  J. Kanis,et al.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report , 1994, Osteoporosis International.

[9]  R. Prentice,et al.  Maintenance of a low-fat diet: follow-up of the Women's Health Trial. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[10]  M. Moskowitz,et al.  Feasibility of a randomized trial of a low-fat diet for the prevention of breast cancer: dietary compliance in the Women's Health Trial Vanguard Study. , 1990, Preventive medicine.

[11]  G. Luc,et al.  A selective bi-site immunoenzymatic procedure for human Lp[a] lipoprotein quantification using monoclonal antibodies against apo[a] and apoB. , 1989, Journal of lipid research.

[12]  S. J. Smith,et al.  The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements. , 1989, Clinics in laboratory medicine.

[13]  I M Buzzard,et al.  Sources of data for developing and maintaining a nutrient database. , 1988, Journal of the American Dietetic Association.

[14]  K. Wells,et al.  Development of a Brief Screening Instrument for Detecting Depressive Disorders , 1988, Medical care.

[15]  W Insull,et al.  Statistical design of the Women's Health Trial. , 1988, Controlled clinical trials.

[16]  E. Lakatos,et al.  Sample sizes based on the log-rank statistic in complex clinical trials. , 1988, Biometrics.

[17]  K. Miller,et al.  Simultaneous determination of plasma retinol, α-tocopherol, lycopene, α-carotene, and β-carotene by high-performance liquid chromatography , 1984 .

[18]  B. Osterud,et al.  The interaction of human blood coagulation factor VII and tissue factor: the effect of anti factor VII, anti tissue factor and diisopropylfluorophosphate. , 1979, Biochemical and biophysical research communications.

[19]  B. Slavin.  Fundamentals of Clinical Chemistry , 1977 .

[20]  J. Peterson,et al.  Evaluation of the hexokinase-glucose-6-phosphate dehydrogenase method of determination of glucose in urine. , 1968, Analytical biochemistry.

[21]  A. Clauss,et al.  Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .

[22]  JoAnn E. Manson,et al.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.

[23]  L. Kaplan,et al.  Simultaneous measurement of serum retinol, tocopherols, carotenes, and carotenoids by high performance liquid chromatography , 1987 .

[24]  J. Albers,et al.  Estimating , 2021, Project Management, Planning and Control.